Molly MacDonald turned adversity into action, founding The Pink Fund to support breast cancer patients. Her journey reveals powerful lessons on resilience and leadership.

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that short-course, higher dose vaginal brachytherapy for endometrial cancer had ...

Endometrial cancer (EC) is the most common gynecological malignancy in developed countries, with its incidence steadily rising worldwide due to increasing ...

In a randomized clinical trial, researchers from Huntsman Cancer Institute at the University of Utah (the U) have found that ...

A 58-year-old woman mistook her womb cancer symptoms for menopause until her stomach became swollen. Diagnosed with ...

Recent studies show how dietary choices may affect a person's risk of cancer, particularly colorectal cancer, and cancer of ...

A woman who thought she was experiencing symptoms of the menopause actually went on to be diagnosed with womb cancer and now ...

He revealed, “The aim of radiation therapy is to deliver a precise measured dose of radiation to a defined tumour volume with ...

The ACR-368-tailored OncoSignature assay is being used to predict patients most likely to respond to ACR-368 in Acrivon’s ongoing, ...

What causes cancer? The 12 most dangerous things you can do for your health - Dr Liz O’Riordan, a breast cancer surgeon and ...

The five most common cancers are breast (16.8%), lip and oral cavity (8.4%), stomach (7.0%), larynx (7.0%), and cervix (5.1%) ...

IMA-402 is under clinical development by Immatics and currently in Phase II for Uterine Cancer. According to GlobalData, Phase II drugs for Uterine Cancer have a 30% phase transition success rate ...